首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
【24h】

Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma

机译:新辅助放化疗和食管切除术的病理分期可更好地预测食管鳞状细胞癌患者的生存

获取原文
获取原文并翻译 | 示例
       

摘要

Background and purpose: To assess the usefulness of pathological stage according to the 7th edition of the Union for International Cancer Control-American Joint Committee on Cancer (UICC-AJCC) as a prognostic tool in patients undergoing neoadjuvant chemoradiation followed by esophagectomy (trimodality therapy, TMT) for locally advanced esophageal squamous cell carcinoma.
机译:背景与目的:根据国际癌症控制联盟-美国癌症联合委员会(UICC-AJCC)第七版评估病理分期的有效性,将其作为新辅助化学放疗后食管切除术(三联疗法, TMT)用于局部晚期食管鳞状细胞癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号